arrow
P

Paul Brennan

University of Edinburgh
H指数:26
被引数:2,450

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma

肝病学:MASLD、病毒性肝炎、胆汁淤积性肝病、门静脉高压和肝细胞癌的新兴范式

2026-08-300
PRE
2026-07-010
PRE
Assessing Europe's policy readiness to confront the MASLD/MASH public health threat

评估欧洲应对MASLD/MASH公共卫生威胁的政策准备情况

2026-05-250
OAAI
Implementation of evidence-based alcohol policies to reduce alcohol-related harm and liver disease to advance public health in Europe

实施循证酒精政策以减少酒精相关危害和肝脏疾病,促进欧洲公共卫生

2026-05-250
OAAI
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease

脂肪性肝病的纤维化诊断创新和护理模式以改善纤维化检测和风险分层

2026-05-250
OAAI
Supplementary Material for Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data from Nine Countries

代谢功能障碍相关脂肪性肝炎(MASH)的全球临床、人文和经济影响预测项目补充资料:基于九国数据的无所作为的成本

2025-09-080
PRE
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice

没有变化就不可能取得进展: 了解脂肪肝疾病的演变命名法及其对肝脏病学实践的影响

2024-06-013
OAAI